TEX22 Inhibitors
TEX22 inhibitors are a class of chemical compounds designed to selectively interfere with the function of the TEX22 protein. TEX22, a member of the testis-expressed (TEX) protein family, plays a role in specific cellular pathways, often related to its expression in certain tissues or cell types. Inhibitors targeting TEX22 are structured to bind to specific sites on the protein, thereby modulating its normal biological activity. These compounds typically exhibit high affinity for TEX22, enabling researchers to study the protein's role in various molecular processes. The design of TEX22 inhibitors is often guided by structural biology insights, such as crystallography or computational modeling, which help to identify binding sites and key interactions critical for their inhibitory effects. Chemical synthesis of these inhibitors can involve modifications to enhance binding efficiency, stability, or selectivity for TEX22 over related proteins.
In experimental settings, TEX22 inhibitors are valuable tools for probing the molecular and biochemical pathways regulated by TEX22. By inhibiting TEX22 activity, researchers can observe downstream effects and better understand how TEX22 interacts with other proteins or cellular systems. The development of these inhibitors involves rigorous testing, including the examination of their binding kinetics, specificity, and their effects on protein conformation. Studies often focus on the molecular dynamics and structural changes that occur when TEX22 is inhibited, providing insights into its biological roles. These inhibitors are crucial for dissecting the fundamental biology of TEX22, offering a window into the complex regulatory networks that involve this protein and its associated functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. TEX22 function may be impacted through the cell cycle regulation pathway, as these kinases are crucial for cell cycle progression from the G1 to the S phase. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
MDM2 antagonist that prevents the MDM2-p53 interaction, leading to stabilization and activation of p53. Activation of p53 can result in cell cycle arrest, which could indirectly inhibit TEX22 by limiting cell proliferation where TEX22 is expressed. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that causes hyperacetylation of histones, leading to changes in chromatin structure and gene expression. This could inhibit TEX22 by altering the expression of genes required for its function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that prevents the degradation of ubiquitinated proteins, potentially leading to cell cycle arrest and apoptosis. This could decrease TEX22 activity by disrupting proteostasis and cell division processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibitor of the Rho-associated protein kinase (ROCK), which plays a role in actin cytoskeleton organization. Altering cytoskeletal dynamics can affect cell division and thus potentially decrease TEX22 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that impairs the MAPK/ERK signaling pathway, which is involved in cell proliferation and survival. This may reduce TEX22 activity by impeding pathways that are crucial for testis development and function where TEX22 is active. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibitor of PI3K, which leads to suppression of the AKT signaling pathway. This could reduce TEX22 activity by affecting pathways essential for cell survival and growth in tissues where TEX22 is implicated. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibitor of the TGF-β receptor kinases ALK4, ALK5, and ALK7, impacting cell differentiation and proliferation. This could indirectly decrease TEX22 activity in developmental processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that affects cell growth, proliferation, and survival by inhibiting the mTORC1 complex. This could diminish TEX22 activity by reducing cellular processes where it may be involved. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibitor of MEK1/2, which are part of the MAPK/ERK pathway. This may indirectly inhibit TEX22 by affecting signaling pathways critical for cell growth and division where TEX22 plays a role. | ||||||